Security
Utah Medical Products, Inc. Common Stock · UTMD
UTMDNASDAQCommon stockCurrentCIK 706698Updated Oct 30, 2026
UTMD price & chart
Loading TradingView…
NASDAQ:UTMD on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
Other Events
Items 8.01, 9.01
SC TO-I/A - filed by UTAH MEDICAL PRODUCTS INC regarding UTAH MEDICAL PRODUCTS INC
Results of Operations and Financial Condition
Items 2.02, 9.01
SC TO-I/A - filed by UTAH MEDICAL PRODUCTS INC regarding UTAH MEDICAL PRODUCTS INC
SC TO-I/A - filed by UTAH MEDICAL PRODUCTS INC regarding UTAH MEDICAL PRODUCTS INC
Show 5 more recent filings
SC TO-C - filed by UTAH MEDICAL PRODUCTS INC regarding UTAH MEDICAL PRODUCTS INC
SC TO-C - filed by UTAH MEDICAL PRODUCTS INC regarding UTAH MEDICAL PRODUCTS INC
SC 13E3 - filed by UTAH MEDICAL PRODUCTS INC regarding UTAH MEDICAL PRODUCTS INC
SC TO-C - filed by UTAH MEDICAL PRODUCTS INC regarding UTAH MEDICAL PRODUCTS INC
Regulation FD Disclosure
Items 7.01
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 121,975,000Source | 129,694,000Source | 124,572,000Source | 120,802,000Source | 130,032,000Source | 124,382,000Source | 122,519,000Source | 135,441,000Source | 122,542,000Source | 122,538,000Source | 135,458,000Source | 123,874,000Source |
| Property, Plant and Equipment, NetUSD | 10,000,000Source | 10,419,000Source | 9,631,000Source | 10,257,000Source | 10,194,000Source | 9,721,000Source | 9,945,000Source | 10,266,000Source | 9,908,000Source | 9,763,000Source | 10,551,000Source | 10,224,000Source |
| GoodwillUSD | 14,051,000Source | 14,027,000Source | 13,956,000Source | 14,193,000Source | 13,640,000Source | 13,919,000Source | 13,770,000Source | 13,638,000Source | 14,052,000Source | 13,580,000Source | 13,692,000Source | 13,354,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 1,392,000Source | 3,592,000Source | 346,000Source | 1,977,000Source | 3,876,000Source | 364,000Source | 2,405,000Source | 4,388,000Source | 840,000Source | 2,865,000Source | 4,946,000Source | 10,377,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 84,267,000Source | 88,452,000Source | 87,528,000Source | 82,179,000Source | 89,219,000Source | 87,406,000Source | 83,325,000Source | 93,808,000Source | 85,756,000Source | 82,976,000Source | 92,868,000Source | 75,052,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 3,725,000Source | 3,720,000Source | 3,565,000Source | 3,632,000Source | 3,668,000Source | 3,636,000Source | 3,944,000Source | 3,591,000Source | 3,522,000Source | 4,094,000Source | 3,391,000Source | 5,538,000Source |
| Inventory, NetUSD | 8,118,000Source | 9,107,000Source | 9,003,000Source | 8,233,000Source | 9,058,000Source | 8,722,000Source | 8,648,000Source | 9,240,000Source | 7,935,000Source | 8,812,000Source | 9,582,000Source | 8,814,000Source |
| Assets, CurrentUSD | 96,532,000Source | 101,656,000Source | 100,639,000Source | 94,375,000Source | 102,322,000Source | 100,378,000Source | 96,399,000Source | 107,149,000Source | 97,742,000Source | 96,330,000Source | 106,269,000Source | 89,919,000Source |
| Operating Lease, Right-of-Use AssetUSD | — | — | — | — | — | — | — | — | 286,000Source | 338,000Source | 342,000Source | 395,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 3,723,000Source | 5,497,000Source | 2,539,000Source | 3,269,000Source | 5,980,000Source | 4,009,000Source | 5,472,000Source | 7,699,000Source | 3,274,000Source | 5,111,000Source | 7,145,000Source | 9,620,000Source |
| Commitments and ContingenciesUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 32,000Source | 34,000Source | 32,000Source | 32,000Source | 35,000Source | 32,000Source | 33,000Source | 36,000Source | 32,000Source | 33,000Source | 36,000Source | 36,000Source |
| Retained Earnings (Accumulated Deficit)USD | 127,958,000Source | 134,053,000Source | 131,954,000Source | 126,863,000Source | 135,339,000Source | 130,260,000Source | 128,204,000Source | 138,995,000Source | 128,652,000Source | 129,302,000Source | 138,341,000Source | 126,006,000Source |
| Stockholders' Equity Attributable to ParentUSD | 118,252,000Source | 124,197,000Source | 122,033,000Source | 117,533,000Source | 124,052,000Source | 120,373,000Source | 117,047,000Source | 127,742,000Source | 119,268,000Source | 117,427,000Source | 128,313,000Source | 114,254,000Source |
| Additional Paid in Capital, Common StockUSD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 594,000Source | 251,000Source |
| Liabilities and EquityUSD | 121,975,000Source | 129,694,000Source | 124,572,000Source | 120,802,000Source | 130,032,000Source | 124,382,000Source | 122,519,000Source | 135,441,000Source | 122,542,000Source | 122,538,000Source | 135,458,000Source | 123,874,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 3,011,000Source | 3,435,000Source | 2,070,000Source | 2,254,000Source | 3,939,000Source | 3,505,000Source | 4,324,000Source | 5,474,000Source | 2,598,000Source | 3,757,000Source | 4,710,000Source | 5,960,000Source |
| Operating Lease, Liability, CurrentUSD | — | — | — | — | — | — | — | — | 60,000Source | 56,000Source | 47,000Source | 54,000Source |
| Accounts Payable, CurrentUSD | 768,000Source | 999,000Source | 876,000Source | 737,000Source | 834,000Source | 1,194,000Source | 914,000Source | 998,000Source | 911,000Source | 696,000Source | 769,000Source | 1,218,000Source |
| Operating Lease, Liability, NoncurrentUSD | — | 299,000Source | — | — | 275,000Source | — | — | 285,000Source | 226,000Source | 282,000Source | 295,000Source | 341,000Source |
| Deferred Income Tax Liabilities, NetUSD | 223,000Source | 286,000Source | 274,000Source | 370,000Source | 208,000Source | 294,000Source | 385,000Source | 256,000Source | 337,000Source | 469,000Source | 322,000Source | 549,000Source |
| Other Liabilities, NoncurrentUSD | — | 698,000Source | — | — | 698,000Source | — | — | 698,000Source | — | 0Source | — | — |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 2,243,000Source | 2,436,000Source | 1,194,000Source | 1,517,000Source | 3,105,000Source | 2,311,000Source | 3,410,000Source | 4,476,000Source | 1,687,000Source | 3,061,000Source | 3,941,000Source | 4,742,000Source |
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 488,000Source | 1,102,000Source | 1,442,000Source | 2,063,000Source |
| Long-term DebtUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | 2,631,000Source | 3,563,000Source | 2,686,000Source | 3,048,000Source | 2,604,000Source | 3,041,000Source | 11,286,000Source | 13,874,000Source | 16,635,000Source | 16,473,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 120,000Source | 82,000Source | 373,000Source | 256,000Source | 225,000Source | 183,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | — | — | -338,000Source | 835,000Source | -2,270,000Source | 511,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 830,000Source | -275,000Source | -1,195,000Source | -587,000Source | 670,000Source | 2,353,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | 284,000Source | 217,000Source | 211,000Source | -73,000Source | -456,000Source | 464,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | -157,000Source | -209,000Source | -614,000Source | -359,000Source | -693,000Source | -401,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | 3,109,000Source | 4,464,000Source | 14,692,000Source | 14,831,000Source | 22,281,000Source | 21,147,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -130,000Source | -184,000Source | -371,000Source | -208,000Source | -639,000Source | -818,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 130,000Source | 184,000Source | 371,000Source | 230,000Source | 639,000Source | 809,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | 128,000Source | 3,221,000Source | 8,355,000Source | 19,968,000Source | 0Source | 2,495,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -1,117,000Source | -4,238,000Source | -12,338,000Source | -23,838,000Source | -4,165,000Source | -5,484,000Source |
| Dividends paid | — | — | — | — | — | — | —Source | —Source | —Source | —Source | —Source | —Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 1,650,000Source | 349,000Source | 2,780,000Source | -9,892,000Source | 17,816,000Source | 14,078,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 84,267,000Source | 88,452,000Source | 87,528,000Source | 82,179,000Source | 87,406,000Source | 83,325,000Source | 85,756,000Source | 82,976,000Source | 92,868,000Source | 75,052,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | -212,000Source | 307,000Source | 797,000Source | -677,000Source | 339,000Source | -767,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | — | 53,000Source | — | — | — | — | 373,000Source | 255,000Source | 225,000Source | 183,000Source |
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | 462,000Source | 509,000Source | 2,126,000Source | 2,065,000Source | 5,692,000Source | 6,417,000Source |
| DepreciationUSD | — | — | — | — | — | — | 211,000Source | 200,000Source | 826,000Source | 730,000Source | 623,000Source | 612,000Source |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber PropertyUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| General and Administrative ExpenseUSD | — | — | — | — | — | — | — | — | 7,880,000Source | 7,835,000Source | 11,016,000Source | 10,406,000Source |
| GoodwillUSD | — | — | 14,051,000Source | 14,027,000Source | 13,956,000Source | 14,193,000Source | 13,919,000Source | 13,770,000Source | 14,052,000Source | 13,580,000Source | 13,692,000Source | 13,354,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Income Tax Expense (Benefit)USD | — | — | 678,000Source | 616,000Source | 600,000Source | 788,000Source | 578,000Source | 817,000Source | 2,824,000Source | 2,928,000Source | 3,454,000Source | 4,186,000Source |
| Other Interest and Dividend IncomeUSD | — | — | — | — | — | — | — | — | 2,808,000Source | 3,367,000Source | 3,036,000Source | 661,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 698,000Source | 836,000Source | 637,000Source | 640,000Source | 617,000Source | 705,000Source | -120,000Source | -174,000Source | 256,000Source | 188,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | 0Source | 0Source | 390,000Source | 117,000Source | 174,000Source |
| Stock or Unit Option Plan ExpenseUSD | — | — | 95,000Source | 53,000Source | 72,000Source | 86,000Source | 120,000Source | 82,000Source | 373,000Source | 256,000Source | 225,000Source | 183,000Source |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
| Operating Expenses | — | — | —Source | —Source | —Source | —Source | —Source | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 9,812,000Source | 10,005,000Source | 8,529,000Source | 9,953,000Source | 8,722,000Source | 9,710,000Source | 38,520,000Source | 40,903,000Source | 50,224,000Source | 52,281,000Source |
| Cost of RevenueUSD | — | — | 4,208,000Source | 4,203,000Source | 3,771,000Source | 4,358,000Source | 3,440,000Source | 4,172,000Source | 16,519,000Source | 16,760,000Source | 20,186,000Source | 20,085,000Source |
| Operating Income (Loss)USD | — | — | 2,611,000Source | 3,343,000Source | 2,649,000Source | 3,196,000Source | 2,565,000Source | 3,153,000Source | 11,402,000Source | 13,594,000Source | 16,777,000Source | 19,790,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 698,000Source | 836,000Source | 637,000Source | 640,000Source | 617,000Source | 705,000Source | -120,000Source | -174,000Source | 256,000Source | 188,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | 3,309,000Source | 4,179,000Source | 3,286,000Source | 3,836,000Source | 3,182,000Source | 3,858,000Source | 14,110,000Source | 16,802,000Source | 20,089,000Source | 20,659,000Source |
| Income Tax Expense (Benefit)USD | — | — | 678,000Source | 616,000Source | 600,000Source | 788,000Source | 578,000Source | 817,000Source | 2,824,000Source | 2,928,000Source | 3,454,000Source | 4,186,000Source |
| Earnings Per Share, BasicUSD per share | — | — | 0.82Source | 1.02Source | 0.84Source | 0.94Source | 0.82Source | 0.92Source | 3.48Source | 3.96Source | 4.58Source | 4.53Source |
| Earnings Per Share, DilutedUSD per share | — | — | 0.82Source | 1.02Source | 0.84Source | 0.94Source | 0.82Source | 0.92Source | 3.48Source | 3.96Source | 4.57Source | 4.52Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 3,207,000Source | 3,478,000Source | 3,184,000Source | 3,246,000Source | 3,185,000Source | 3,310,000Source | 3,240,000Source | 3,503,000Source | 3,629,000Source | 3,637,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 3,207,000Source | 3,478,000Source | 3,184,000Source | 3,246,000Source | 3,185,000Source | 3,310,000Source | 3,240,000Source | 3,503,000Source | 3,637,000Source | 3,643,000Source |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | 462,000Source | 509,000Source | 2,126,000Source | 2,065,000Source | 5,692,000Source | 6,417,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 3,438,000Source | 3,268,000Source | 4,075,000Source | 4,632,000Source |
| General and Administrative ExpenseUSD | — | — | — | — | — | — | — | — | 7,880,000Source | 7,835,000Source | 11,016,000Source | 10,406,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Gross ProfitUSD | — | — | 5,604,000Source | 5,802,000Source | 4,758,000Source | 5,595,000Source | 5,282,000Source | 5,538,000Source | 22,001,000Source | 24,143,000Source | 30,038,000Source | 32,196,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | 11,798,000Source | 13,306,000Source | 11,170,000Source | 12,475,000Source |
| Other Interest and Dividend IncomeUSD | — | — | — | — | — | — | — | — | 2,808,000Source | 3,367,000Source | 3,036,000Source | 661,000Source |
| Research and Development ExpenseUSD | — | — | 167,000Source | 172,000Source | 154,000Source | 135,000Source | 154,000Source | 154,000Source | 668,000Source | 813,000Source | 560,000Source | 493,000Source |
| Selling and Marketing ExpenseUSD | — | — | — | — | — | — | — | — | 2,051,000Source | 1,901,000Source | 1,685,000Source | 1,507,000Source |
| Selling, General and Administrative Expense | — | — | —Source | —Source | —Source | —Source | —Source | —Source | — | — | — | — |
| Operating Expenses | — | — | —Source | —Source | —Source | —Source | —Source | —Source | — | — | — | — |
Filing attachments
utmd_ex107.htm · SC 13E3 · 2026-09-24
EX-FILING FEES CALCULATION OF FILING FEE TABLES SC TO-I UTAH MEDICAL PRODUCTS, INC. Line Item Type Notes Transaction Valuation Fee Rate Amount of Filing Fee ─────────────────────────────────────────────────────────────────────────────────────────────────── Fees to be Paid (1) $48,750,000.00 0.0001381 $6,732.38 Total Transaction Valuation: $48,750,000.00 Total Fees Due for Filing: …
Read attachment ↗